Logo 2021 MediumAsiaWorld-Expo
Hong Kong
Asset 3brandhk sc scaled 2

BIOHK2021 Update 香港国际生物科技展資訊更新

BIOHK is an international convention organized by Hong Kong Biotechnology Organization to introduce novel state-of-the-art biotech innovations from around the globe and provide an extensive platform to allow pioneers of the biotech industry to convene, with the purpose of promoting Hong Kong as an international innovation hub for biotech.

However, due to the COVID-19 epidemic, BIOHK2021 had to be postponed several times and now has been decided to be postponed to 10-13 March 2021. But we are always well-prepared and ready to be the first international biotech convention after pandemic. In view of the continuing uncertainties amidst the COVID-19 epidemic, the safety of participants is definitely our prioritized concern. For any subsequent changes, we will promptly notify all stakeholders and exhibitors for getting better prepared and arranged.

It’s true that COVID-19 brings us plenty of negative impacts, on another hand, it arouses awareness in biotech and speeds up the biotech development. BIOHK2021 must be the first International Biotech Convention when COVID-19 is over. So please reserve your time to join this significant biotech event in Hong Kong.

BIOHK2021 team hereby expresses our gratitude for all those supporting to BIOHK2021. We will continue to try our best in organizing BIOHK2021, which brings biotech industry an international biotech event, with the purpose of promoting the biotech development.

Please visit this website or email to info@biohk.org.hk for any enquiries.





如有查询,请浏览本网站或电邮至 info@biohk.org.hk

HKLife battles to develop diagnostic tests for COVID-19

Both teams of HKLife, in Hong Kong and in Beijing, are working around the clock to develop sensitive and specific diagnostic tests for the new coronavirus COVID-19. Due to the epidemic crisis, the government rapidly put in place compulsory control measures for municipal transportation and postponed resumption to work. This meant that for outsourced experimental reagents, such as enzymes, primers, and reagents, either the items were out of stock or staff members still had not resumed work. Moreover, we could not gain access to viral samples to act as positive controls. All these external factors hindered our progress but our team undertook positive counter measures: where delivery was delayed, we went to pick up in person; where one supplier was out of stock, we contacted ten other suppliers; where necessary, we prepared the reagents ourselves; and we used synthesized plasmids for positive control. We overcame all these difficulties, and each member of the team continues to maintain an enthusiastic and fighting spirit. The test results are very promising and development of the diagnostic tests look close to success. We hope that our diagnosis platforms can help to resolve the urgent need for accurate diagnostics and contribute to the fight against the epidemic.

我们快成功了! 加油!

team hk

Hong Kong team 香港团队
Left to right: Kaka KAR, Iris HO, Queenie FONG, Dr. Zhaoyang YE, Dr. Timothy HO, Dr. Jodie XU
从左至右:賈寶怡、何婉芳、方文君、叶朝阳 博士、何耀昌 博士、徐舟 博士


team bj

Beijing team 北京团队
Left to right: Xiaotian LI、Hexin FEI、Nannan ZHAO、Jing HAN、Yingxiao LIAN、Fumeng LI、Dr. Huajian ZHAO、Qianqian AI、Yi YUE、June WANG、Dr. Xiaowei SHI、Yufen GUO
从左至右:李晓天、费鹤馨、赵楠楠、韩晶、廉迎晓、李付梦、赵化建 博士、艾倩倩、岳艺、王双艳、史小伟 博士、郭玉芬